Clinical trial
Effects of Angiotensin Type 1 Receptor Blockade With Losartan on Insulin Sensitivity and Secretion in Subjects With Type 2 Diabetes and Nephropathy
NCT00361023 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Angiotensin Type 1 Receptor Blockade With Losartan on Insulin Sensitivity and Secretion in Subjects With Type 2 Diabetes and Nephropathy
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- July 31, 2006
- Enrollment
- 25
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy, type 2 diabetes